Healthcare systems face critical staffing crises affecting cancer treatment while AI and advanced diagnostics emerge as solutions for improving patient outcomes and closing healthcare gaps.

Scotland's cancer centres report dangerous treatment delays due to staff shortages, with the Royal College of Radiologists warning the situation will significantly worsen by 2030, threatening patient outcomes across the country.

AI and multimodal data analysis are being leveraged to address the women's health gap, tackling issues from cardiac misdiagnosis to lengthy diagnostic delays for conditions like endometriosis that can take up to 8 years to confirm.

The FDA has expanded pneumococcal vaccine approval to high-risk children and teenagers aged 2-17 with chronic medical conditions, broadening protection against pneumococcal disease in vulnerable populations.

Monoclonal antibody-based therapies can interfere with transfusion testing results, potentially causing dangerous misinterpretations and requiring updated protocols in clinical practice.

A new clinical trial found that high-dose omega-3 supplements, despite reaching the brain, provide no cognitive benefits for older adults at high risk for Alzheimer's disease, questioning their widespread use as preventive therapy.

Protein and creatine supplements have transitioned from niche products to mainstream fitness products, with emerging research exploring their applications for cognitive health and use in patients taking GLP-1 medications.

MRI imaging demonstrates superior predictive accuracy compared to traditional histopathology for preoperative survival and recurrence risk assessment in rectal cancer patients.

Physicians are increasingly integrating AI tools into point-of-care decision-making, representing a significant shift in how clinical diagnostics and treatment recommendations are being delivered in real-time settings.